Exact Mass: 522.1948464
Exact Mass Matches: 522.1948464
Found 500 metabolites which its exact mass value is equals to given mass value 522.1948464
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Isobrucein A
A quassinoid consisting of a heteropentacyclic skeleton containing a delta-lactone moiety which is substituted at the alpha-carbon by a 3-methylbutanoyloxy group.
Icariside E5
Icariside E5 is a glycoside and a stilbenoid. Icariside E5 is a natural product found in Brainea insignis and Capsicum annuum with data available. Icariside E5 is found in fruits. Icariside E5 is a constituent of ripe fruits of Capsicum annuum var. acuminatum
Isolariciresinol 9'-O-beta-D-glucoside
Isolariciresinol 9-O-beta-D-glucoside is a constituent of Scots pine (Pinus sylvestris) needles. Constituent of Scots pine (Pinus sylvestris) needles
(7'R,8'R)-4,7'-Epoxy-3',5-dimethoxy-4',9,9'-lignanetriol 9'-glucoside
(7R,8R)-4,7-Epoxy-3,5-dimethoxy-4,9,9-lignanetriol 9-glucoside is found in alcoholic beverages. (7R,8R)-4,7-Epoxy-3,5-dimethoxy-4,9,9-lignanetriol 9-glucoside is isolated from Riesling wine. Isolated from Riesling wine. (7R,8R)-4,7-Epoxy-3,5-dimethoxy-4,9,9-lignanetriol 9-glucoside is found in alcoholic beverages.
Isolariciresinol 4'-O-beta-D-glucoside
Isolariciresinol 4-O-beta-D-glucoside is found in alcoholic beverages. Isolariciresinol 4-O-beta-D-glucoside is a constituent of Riesling wine. Constituent of Riesling wine. Isolariciresinol 4-O-beta-D-glucoside is found in alcoholic beverages.
Isolariciresinol 9-O-beta-D-glucoside
Isolariciresinol 9-O-beta-D-glucoside is a constituent of Scots pine (Pinus sylvestris) needles. Constituent of Scots pine (Pinus sylvestris) needles.
Ticagrelor
Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.
Prednisolone phthalate
BRUCEIN A
Bruceine A is a quassinoid. Bruceine A is a natural product found in Brucea javanica with data available. Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. IC50 value: Target: Bruceine A inhibited the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration compared with the standard antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nM. Oral administration of bruceine A at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog with normal ranges of hematological and biochemical values in the blood. Three dogs were infected with B. gibsoni and two of them were treated with bruceine A at a dosage of 6.4 mg/kg/day for 6 days from day 5 post-infection. Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. IC50 value: Target: Bruceine A inhibited the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration compared with the standard antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nM. Oral administration of bruceine A at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog with normal ranges of hematological and biochemical values in the blood. Three dogs were infected with B. gibsoni and two of them were treated with bruceine A at a dosage of 6.4 mg/kg/day for 6 days from day 5 post-infection.
Bruceine
Bruceine A is a quassinoid. Bruceine A is a natural product found in Brucea javanica with data available. Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. IC50 value: Target: Bruceine A inhibited the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration compared with the standard antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nM. Oral administration of bruceine A at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog with normal ranges of hematological and biochemical values in the blood. Three dogs were infected with B. gibsoni and two of them were treated with bruceine A at a dosage of 6.4 mg/kg/day for 6 days from day 5 post-infection. Bruceine A(NSC310616; Dihydrobrusatol) is a natural quassinoid compound extracted from the dried fruits of Brucea javanica (L.); are potential candidates for the treatment of canine babesiosis. IC50 value: Target: Bruceine A inhibited the in vitro growth of Babesia gibsoni in canine erythrocytes at lower concentration compared with the standard antibabesial drug diminazene aceturate and killed the parasites within 24 hr at a concentration of 25 nM. Oral administration of bruceine A at a dosage of 6.4 mg/kg/day for 5 days resulted in no clinical findings in a dog with normal ranges of hematological and biochemical values in the blood. Three dogs were infected with B. gibsoni and two of them were treated with bruceine A at a dosage of 6.4 mg/kg/day for 6 days from day 5 post-infection.
trans-Dihydrodehydrodiconiferyl alcohol-9-O-beta-D-glucoside
(2S,3R)-Dihydrodehydrodiconiferyl alcohol beta-D-glucoside
Neocandenatone
(7S,8R)-Dehydrodiconiferyl alcohol 9-O-beta-glucopyranoside
(2R,3R,4S,5S,6R)-2-[3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
4-{2-[[3-(4-hydroxy-3-methoxyphenyl)-2-propenyl]oxy]ethyl}-2,6-dimethoxyphenyl-beta-D-glucopyranoside
(+)-lariciresinol-4-O-beta-D-glucopyranoside|(-)-lariciresinol-4-O-beta-D-glucopyranoside|7S,8R,8R-(-)-lariciresinol-4-O-beta-D-glucopyranoside|lariciresinol 4-O-beta-D-glucopyranoside
2-[4,5-Dimethoxy-5-(3-phenyl-trans-allyl)cyclohexa-3,6-dien-2-on-1-ylmethyl]-5-hydroxy-6-methoxy-3-phenylbenzofuran
5-Hydroxy-7-methoxy-3,4-diacetoxy-6-(6,6-dimethyl-2-oxo-cyclohexylmethyl)flavone
11beta,12beta-Epoxide,2,3,14-tri-Ac-8,17-Epoxy-2,3,9,14-tetrahydroxy-5,11-briaradien-18,7-olide
10-O-benzoyl-10-O-deacetyl-11-demethoxy-11-ethoxydaphylloside|ethyl(1S,4aS,5S,7aS)-7-[(benzoyloxy)methyl]-1-(beta-D-glucopyranosyloxy)-1,4a,5,7a,-tetrahydro-5-hydroxycyclopenta[c]pyran-4-carboxylate
(-)-4,4,9-trihydroxy-3,5-dimethoxy-2,7-cyclolignan 9-O-beta-D-glucopyranoside
4-cumaryl alcohol 4-O-beta-D-glucopyranoside peracetate|[4-(3-Acetoxy-trans-propenyl)-phenyl]-(tetra-O-acetyl-beta-D-glucopyranosid)|[4-(3-acetoxy-trans-propenyl)-phenyl]-(tetra-O-acetyl-beta-D-glucopyranoside)
11,16-dihydroxy-12-O-beta-D-glucopyranosyl-17(15->16),18(4->3)-abeo-4-carboxy-3,8,11,13-abietatetraen-7-one
5-methoxy-9-beta-xylopyranosyl-(-)-isolariciresinol
2-(3,5-Dimethoxy-4-(3,4,5-trihydroxytetrahydro-2H-pyran-2-yloxy)phenyl)-3-hydroxymethyl-7-methoxy-2,3-dihydrobenzofuran 5-(1-propanol)
seco-dehydrodiconiferyl alcohol-4-O-beta-D-glucopyranoside
benzyl 2-O-beta-D-apiofuranosyl-(1?2)-beta-D-glucopyranosylbenzoate
1beta-(3-furanoyloxy)-9alpha-benzoyloxy-8beta-acetoxy-2-oxo-3-enedihydro-beta-agarofuran
[(1S,2S,3R)-1,2,3,4-tetrahydro-7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxynaphthalen-2-yl]methyl beta-D-xylopyranoside
(11beta)-1,2,21,23-tetrahydro-11,23-dihydroxy-21-oxoobacunoic acid
2-[4,5-Dimethoxy-2-(3-phenyl-trans-allyloxy)benzyl]-5-hydroxy-6-methoxy-3-phenylbenzofuran
Urolignoside
Urolignoside is a natural product found in Salacia chinensis, Keteleeria evelyniana, and other organisms with data available.
(+)-Isolariciresinol 9O-Glucoside
(+)-Isolariciresinol 9-O-glucoside is a natural product found in Pedicularis densispica, Glochidion zeylanicum, and other organisms with data available.
10-O-Trans-p-methoxycinnamoylcatalpol
Azatadine maleate
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Azatadine bimaleate is an inhibitor of histamine receptors and choline receptors with IC50s of 6.5 nM and 10 nM respectively.
Ticagrelor
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.
Asperphenamate analogue phenylalanine to tyrosine substitution
(7R,8S)-dihydrodehydrodiconiferyl alcohol 9-O-beta-D-glucopyranoside
(2R,3R,4S,5S,6R)-2-[[7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-(hydroxymethyl)-6-[5-[3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
C25H30O12_(5E)-5-[2-(beta-D-Glucopyranosyloxy)ethylidene]-4-{[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]oxy}-2-methyl-1-cyclopentene-1-carboxylic acid
C22H34O14_Hexitol, 2,6-anhydro-, 5-[4-(beta-D-glucopyranosyloxy)-2-methylenebutanoate] 1-(4-hydroxy-2-methylenebutanoate)
C25H30O12_(1S,4aS,6S,7R,7aS)-1-(beta-D-Glucopyranosyloxy)-6-{[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]oxy}-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid
C26H34O11_beta-D-Glucopyranoside, [(2R,3R)-2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-3-benzofuranyl]methyl
C26H34O11_[(2R,3R,4S)-6-Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]methyl beta-D-glucopyranoside
C26H34O11_3-[2-(4-Hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propyl beta-D-glucopyranoside
C26H34O11_2-{2-Hydroxy-5-[(1E)-3-hydroxy-1-propen-1-yl]-3-methoxyphenyl}-3-(4-hydroxy-3-methoxyphenyl)propyl hexopyranoside
C25H30O12_Cyclopenta[c]pyran-4-carboxylic acid, 1,4a,5,6,7,7a-hexahydro-7-hydroxy-1-[[2-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-glucopyranosyl]oxy]-7-methyl-, (1S,4aS,7R,7aS)
2-(hydroxymethyl)-6-[5-[3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol
(2R,3R,4S,5S,6R)-2-[[7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2R,3R,4S,5S,6R)-2-[[7-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
(2R,3R,4S,5S,6R)-2-[3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]propoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major
2-(hydroxymethyl)-6-[5-[3-(hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]oxane-3,4,5-triol_major
Cys His Thr Tyr
Cys His Tyr Thr
Cys Met Asn Arg
C18H34N8O6S2 (522.2042624000001)
Cys Met Arg Asn
C18H34N8O6S2 (522.2042624000001)
Cys Asn Met Arg
C18H34N8O6S2 (522.2042624000001)
Cys Asn Arg Met
C18H34N8O6S2 (522.2042624000001)
Cys Asn Thr Trp
Cys Asn Trp Thr
Cys Gln Ser Trp
Cys Gln Trp Ser
Cys Arg Met Asn
C18H34N8O6S2 (522.2042624000001)
Cys Arg Asn Met
C18H34N8O6S2 (522.2042624000001)
Cys Ser Gln Trp
Cys Ser Trp Gln
Cys Thr His Tyr
Cys Thr Asn Trp
Cys Thr Trp Asn
Cys Thr Tyr His
Cys Trp Asn Thr
Cys Trp Gln Ser
Cys Trp Ser Gln
Cys Trp Thr Asn
Cys Tyr His Thr
Cys Tyr Thr His
Asp Asp His His
Asp Glu Pro Tyr
Asp Glu Tyr Pro
Asp Phe Asn Gln
Asp Phe Gln Asn
Asp His Asp His
Asp His His Asp
Asp Asn Phe Gln
Asp Asn Gln Phe
Asp Pro Glu Tyr
Asp Pro Tyr Glu
Asp Gln Phe Asn
Asp Gln Asn Phe
Asp Tyr Glu Pro
Asp Tyr Pro Glu
Glu Asp Pro Tyr
Glu Asp Tyr Pro
Glu Phe Met Pro
Glu Phe Asn Asn
Glu Phe Pro Met
Glu His His Thr
Glu His Thr His
Glu Ile Met Met
Glu Leu Met Met
Glu Met Phe Pro
Glu Met Ile Met
Glu Met Leu Met
Glu Met Met Ile
Glu Met Met Leu
Glu Met Pro Phe
Glu Asn Phe Asn
Glu Asn Asn Phe
Glu Pro Asp Tyr
Glu Pro Phe Met
Glu Pro Met Phe
Glu Pro Tyr Asp
Glu Thr His His
Glu Tyr Asp Pro
Glu Tyr Pro Asp
Phe Asp Asn Gln
Phe Asp Gln Asn
Phe Glu Met Pro
Phe Glu Asn Asn
Phe Glu Pro Met
Phe Gly His Tyr
Phe Gly Asn Trp
Phe Gly Trp Asn
Phe Gly Tyr His
Phe His Gly Tyr
Phe His Tyr Gly
Phe Met Glu Pro
Phe Met Pro Glu
Phe Asn Asp Gln
Phe Asn Glu Asn
Phe Asn Gly Trp
Phe Asn Asn Glu
Phe Asn Gln Asp
Phe Asn Trp Gly
Phe Pro Glu Met
Phe Pro Met Glu
Phe Gln Asp Asn
Phe Gln Asn Asp
Phe Trp Gly Asn
Phe Trp Asn Gly
Phe Tyr Gly His
Phe Tyr His Gly
Gly Phe His Tyr
Gly Phe Asn Trp
Gly Phe Trp Asn
Gly Phe Tyr His
Gly His Phe Tyr
Gly His Tyr Phe
Gly Asn Phe Trp
Gly Asn Trp Phe
Gly Trp Phe Asn
Gly Trp Asn Phe
Gly Tyr Phe His
Gly Tyr His Phe
His Cys Thr Tyr
His Cys Tyr Thr
His Asp Asp His
His Asp His Asp
His Glu His Thr
His Glu Thr His
His Phe Gly Tyr
His Phe Tyr Gly
His Gly Phe Tyr
His Gly Tyr Phe
His His Asp Asp
His His Glu Thr
His His Thr Glu
His Thr Cys Tyr
His Thr Glu His
His Thr His Glu
His Thr Tyr Cys
His Tyr Cys Thr
His Tyr Phe Gly
His Tyr Gly Phe
His Tyr Thr Cys
Ile Glu Met Met
Ile Met Glu Met
Ile Met Met Glu
Leu Glu Met Met
Leu Met Glu Met
Leu Met Met Glu
Met Cys Asn Arg
C18H34N8O6S2 (522.2042624000001)
Met Cys Arg Asn
C18H34N8O6S2 (522.2042624000001)
Met Glu Phe Pro
Met Glu Ile Met
Met Glu Leu Met
Met Glu Met Ile
Met Glu Met Leu
Met Glu Pro Phe
Met Phe Glu Pro
Met Phe Pro Glu
Met Ile Glu Met
Met Ile Met Glu
Met Leu Glu Met
Met Leu Met Glu
Met Met Glu Ile
Met Met Glu Leu
Met Met Ile Glu
Met Met Leu Glu
Met Met Asn Gln
Met Met Gln Asn
Met Asn Cys Arg
C18H34N8O6S2 (522.2042624000001)
Met Asn Met Gln
Met Asn Gln Met
Met Asn Arg Cys
C18H34N8O6S2 (522.2042624000001)
Met Pro Glu Phe
Met Pro Phe Glu
Met Gln Met Asn
Met Gln Asn Met
Met Arg Cys Asn
C18H34N8O6S2 (522.2042624000001)
Met Arg Asn Cys
C18H34N8O6S2 (522.2042624000001)
Asn Cys Met Arg
C18H34N8O6S2 (522.2042624000001)
Asn Cys Arg Met
C18H34N8O6S2 (522.2042624000001)
Asn Cys Thr Trp
Asn Cys Trp Thr
Asn Asp Phe Gln
Asn Asp Gln Phe
Asn Glu Phe Asn
Asn Glu Asn Phe
Asn Phe Asp Gln
Asn Phe Glu Asn
Asn Phe Gly Trp
Asn Phe Asn Glu
Asn Phe Gln Asp
Asn Phe Trp Gly
Asn Gly Phe Trp
Asn Gly Trp Phe
Asn Met Cys Arg
C18H34N8O6S2 (522.2042624000001)
Asn Met Met Gln
Asn Met Gln Met
Asn Met Arg Cys
C18H34N8O6S2 (522.2042624000001)
Asn Asn Glu Phe
Asn Asn Phe Glu
Asn Gln Asp Phe
Asn Gln Phe Asp
Asn Gln Met Met
Asn Arg Cys Met
C18H34N8O6S2 (522.2042624000001)
Asn Arg Met Cys
C18H34N8O6S2 (522.2042624000001)
Asn Thr Cys Trp
Asn Thr Trp Cys
Asn Trp Cys Thr
Asn Trp Phe Gly
Asn Trp Thr Cys
Pro Asp Glu Tyr
Pro Asp Tyr Glu
Pro Glu Asp Tyr
Pro Glu Phe Met
Pro Glu Met Phe
Pro Glu Tyr Asp
Pro Phe Glu Met
Pro Phe Met Glu
Pro Met Glu Phe
Pro Met Phe Glu
Pro Tyr Asp Glu
Pro Tyr Glu Asp
Gln Cys Ser Trp
Gln Cys Trp Ser
Gln Asp Phe Asn
Gln Asp Asn Phe
Gln Phe Asp Asn
Gln Phe Asn Asp
Gln Met Met Asn
Gln Met Asn Met
Gln Asn Asp Phe
Gln Asn Phe Asp
Gln Asn Met Met
Gln Ser Cys Trp
Gln Ser Trp Cys
Gln Trp Cys Ser
Gln Trp Ser Cys
Arg Cys Met Asn
C18H34N8O6S2 (522.2042624000001)
Arg Cys Asn Met
C18H34N8O6S2 (522.2042624000001)
Arg Met Cys Asn
C18H34N8O6S2 (522.2042624000001)
Arg Met Asn Cys
C18H34N8O6S2 (522.2042624000001)
Arg Asn Cys Met
C18H34N8O6S2 (522.2042624000001)
Arg Asn Met Cys
C18H34N8O6S2 (522.2042624000001)
Ser Cys Gln Trp
Ser Cys Trp Gln
Ser Gln Cys Trp
Ser Gln Trp Cys
Ser Trp Cys Gln
Ser Trp Gln Cys
Thr Cys His Tyr
Thr Cys Asn Trp
Thr Cys Trp Asn
Thr Cys Tyr His
Thr Glu His His
Thr His Cys Tyr
Thr His Glu His
Thr His His Glu
Thr His Tyr Cys
Thr Asn Cys Trp
Thr Asn Trp Cys
Thr Trp Cys Asn
Thr Trp Asn Cys
Thr Tyr Cys His
Thr Tyr His Cys
Trp Cys Asn Thr
Trp Cys Gln Ser
Trp Cys Ser Gln
Trp Cys Thr Asn
Trp Asn Cys Thr
Trp Asn Thr Cys
Trp Gln Cys Ser
Trp Gln Ser Cys
Trp Ser Cys Gln
Trp Ser Gln Cys
Trp Thr Cys Asn
Trp Thr Asn Cys
Tyr Cys His Thr
Tyr Cys Thr His
Tyr Asp Glu Pro
Tyr Asp Pro Glu
Tyr Glu Asp Pro
Tyr Glu Pro Asp
Tyr His Cys Thr
Tyr His Thr Cys
Tyr Pro Asp Glu
Tyr Pro Glu Asp
Tyr Thr Cys His
Tyr Thr His Cys
Isolariciresinol 9-O-b-D-glucoside
Icariside E5
Constituent of ripe fruits of Capsicum annuum variety acuminatum. Icariside E5 is found in many foods, some of which are green bell pepper, yellow bell pepper, red bell pepper, and herbs and spices.
(7'R,8'R)-4,7'-Epoxy-3',5-dimethoxy-4',9,9'-lignanetriol 9'-glucoside
Isolariciresinol 9'-O-b-D-glucoside
Isolariciresinol 4'-O-b-D-glucoside
5-[3-(Hydroxymethyl)-5-(3-hydroxypropyl)-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenyl hexopyranoside
Vanoxerine dihydrochloride
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
1,1-(Decane-1,10-diyl)bis[4-aza-1-azoniabicyclo[2.2.2]octane] Dibromide
1-[4-[[4-[(5-Cyclopentyl-1h-Pyrazol-3-Yl)amino]pyrimidin-2-Yl]amino]phenyl]-3-[3-(Trifluoromethyl)phenyl]urea
2-methyl-6-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O3-ethyl ester O5-[(4-nitrophenyl)methyl] ester
MRS1334 is a potent and selective human adenosine A3 receptor antagonist with Kis of 2.69 nM, >100 nM, >100 nM for hA3, rA1, rA2A, respectively. MRS1334 blocks the protective effect of Cl-IB-MECA leading to significant bradycardia and elevated ST segment[1][2]. MRS1334 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
[[(2R,3R)-2,3-Dihydro-2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxybenzofuran-3-yl]methyl]beta-D-glucopyranoside
N-alpha-(2-Naphthylsulfonyl)-N(3-amidino-L-phenylalaninyl)isopipecolinic acid methyl ester
2-[4-[4-[(4-Hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2-[[2-(4-Hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (4S,5E,6S)-5-ethylidene-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(1R,2R,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy-4H-pyran-3-carboxylate
23,26-Dihydroxy-23-(2-hydroxyacetyl)-1,24-dimethyl-3,12-dioxahexacyclo[14.11.0.02,13.05,10.019,27.020,24]heptacosa-2(13),5,7,9,15-pentaene-4,11,14-trione
Baeckea frutescens 6
D001697 - Biomedical and Dental Materials > D003764 - Dental Materials
3-[[2,3-Dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxybenzofuran]-5-yl]propyl beta-D-glucopyranoside
[3,4-dihydroxy-5-[2-methylidene-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanoyl]oxyoxan-2-yl]methyl 4-hydroxy-2-methylidenebutanoate
3,15-Di-O-acetylbruceolide
A quassinoid that is the 3,15-di-O-acetyl derivative of bruceolide. It has been isolated from Brucea javanica and Brucea sumatrana.
4-methyl-N-[5-[2-[2-[[1-[(4-methylphenyl)methyl]indol-3-yl]methylidene]hydrazinyl]-2-oxidanylidene-ethyl]-1,3,4-thiadiazol-2-yl]benzamide
9-[5-Carboxy-2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthenium chloride
5-(beta-D-glucopyranosyloxy)-1H-naphtho[2,3-c]pyran-10-yl beta-D-quinovopyranoside
[(1R)-2-[(4-chlorophenyl)methyl]-7-methoxy-1-(2-thiazolylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
1-(4-fluorophenyl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
[(1S)-2-[(4-chlorophenyl)methyl]-7-methoxy-1-(2-thiazolylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
(3S)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid ethyl ester
1-(4-fluorophenyl)-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-(4-fluorophenyl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-(4-fluorophenyl)-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-(4-fluorophenyl)-3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
1-(4-fluorophenyl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
1-(4-fluorophenyl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-(4-fluorophenyl)-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-(4-fluorophenyl)-3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-(4-fluorophenyl)-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylbenzenesulfonamide
(3R)-2-tert-butylsulfinyl-3-(2-hydroxyethyl)-4-[3-(3-methoxyphenyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxylic acid ethyl ester
5-[(E)-2-[(2S,3R,4S)-3-ethenyl-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]ethenyl]-1-ethylpyridin-1-ium-3-carboxylic acid
(2S,3R,4S)-4-[(E)-2-[1-(3-carboxypropyl)pyridin-1-ium-3-yl]ethenyl]-3-ethenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
(+)-Isolariciresinol-3alpha-O-beta-D-glucopyranoside
(1R,2S,3R,5S)-3-[7-[[(1R,2R)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
(2-Benzamido-3-phenylpropyl) 2-benzamido-3-(4-hydroxyphenyl)propanoate
(7R,8R)-4,7-Epoxy-3,5-dimethoxy-4,9,9-lignanetriol 9-glucoside
clarinoside
A naphthopyran that is 1H-naphtho[2,3-c]pyran-5,10-diol in which the hydroxy group at position 5 (furthest from the pyran oxygen) has been converted to the corresponding beta-D-glucoside, while that at position 10 has been converted to the corresponding 6-deoxy-beta-D-glucopyranoside (beta-D-quinovoside). It was isolated from the flowered aerial parts of the annual plant Mitracarpus scaber.
BF 6
An organic heterotetracyclic compound that is 8,12-dihydro-2H,9H-pyrano[2,3-a]xanthene-4,9,11(3H,10H)-trione substituted by methyl groups at positions 6, 8, 8, 10 and 10 and phenyl groups at positions 2 and 12 respectively (the S-enantiomer). It is isolated from the leaves of Baeckea frutescens and exhibits cytotoxicity against leukemia cells.